NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 3 filers reported holding NUVALENT INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,559 | +53.7% | 643 | +41.0% | 0.00% | 0.0% |
| Q2 2023 | $19,229 | +7979.4% | 456 | -95.0% | 0.00% | -87.5% |
| Q1 2023 | $238 | +852.0% | 9,107 | +981.6% | 0.01% | +700.0% |
| Q4 2022 | $25 | -100.0% | 842 | -88.3% | 0.00% | -50.0% |
| Q3 2022 | $140,000 | -25.1% | 7,171 | -47.9% | 0.00% | -50.0% |
| Q2 2022 | $187,000 | +1770.0% | 13,768 | +1770.7% | 0.00% | – |
| Q1 2022 | $10,000 | -73.0% | 736 | -61.8% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | +131.2% | 1,928 | +164.5% | 0.00% | – |
| Q3 2021 | $16,000 | – | 729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,788,981 | $83,055,854 | 13.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $595,332,695 | 12.32% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $106,531 | 11.90% |
| COMMODORE CAPITAL LP | 913,621 | $27,208 | 4.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 302,963 | $9,022,238 | 2.58% |
| Boxer Capital, LLC | 1,210,192 | $36,039,518 | 1.90% |
| Perceptive Advisors | 2,255,007 | $67,154,108 | 1.89% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,673,214 | $49,828,313 | 0.74% |
| Avoro Capital Advisors LLC | 1,555,555 | $46,324,428 | 0.69% |
| AlphaCentric Advisors LLC | 15,500 | $461,590 | 0.46% |